Skip to main content
OpenTrials

Clinical trial condition

Recurrent Childhood Central Nervous System Embryonal Tumor

Explore clinical trials studying Recurrent Childhood Central Nervous System Embryonal Tumor. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Childhood Central Nervous System Embryonal Tumor trial results

Completed

Sunitinib in Treating Young Patients With Refractory Solid Tumors

NCT00387920

Conditions
Central Nervous System Metastases, Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • UCSF-Mount Zion San Francisco, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment

NCT00929903

Conditions
Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, +28 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

NCT01076530

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +67 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
  • University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details

Related conditions